Ebos Group Limited Stock Fundamentals
| EBOSY Stock | USD 35.03 0.00 0.00% |
By evaluating key metrics such as revenue growth, profitability, cash flow trends, and balance sheet strength, investors can better assess EBOS Group's long-term financial health and intrinsic value.
EBOS |
EBOS Group Limited Company Operating Margin Analysis
EBOS Group's Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations.
Current EBOS Group Operating Margin | 0.03 % |
Most of EBOS Group's fundamental indicators, such as Operating Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, EBOS Group Limited is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
A good Operating Margin is required for a company to be able to pay for its fixed costs or payout its debt, which implies that the higher the margin, the better. This ratio is most effective in evaluating the earning potential of a company over time when comparing it against a firm's competitors.
| Competition |
Based on the recorded statements, EBOS Group Limited has an Operating Margin of 0.0314%. This is 100.09% lower than that of the Healthcare sector and 99.56% lower than that of the Medical Distribution industry. The operating margin for all United States stocks is 100.57% lower than that of the firm.
EBOS Group Limited Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining EBOS Group's current stock value. Our valuation model uses many indicators to compare EBOS Group value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across EBOS Group competition to find correlations between indicators driving EBOS Group's intrinsic value. More Info.EBOS Group Limited is one of the top stocks in return on equity category among its peers. It also is one of the top stocks in return on asset category among its peers reporting about 0.40 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for EBOS Group Limited is roughly 2.49 . Comparative valuation analysis is a catch-all model that can be used if you cannot value EBOS Group by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for EBOS Group's Pink Sheet. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.EBOS Operating Margin Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses EBOS Group's direct or indirect competition against its Operating Margin to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of EBOS Group could also be used in its relative valuation, which is a method of valuing EBOS Group by comparing valuation metrics of similar companies.EBOS Group is currently under evaluation in operating margin category among its peers.
EBOS Fundamentals
| Return On Equity | 0.11 | |||
| Return On Asset | 0.0449 | |||
| Profit Margin | 0.02 % | |||
| Operating Margin | 0.03 % | |||
| Current Valuation | 5.9 B | |||
| Shares Outstanding | 94.69 M | |||
| Price To Book | 2.92 X | |||
| Price To Sales | 0.49 X | |||
| Revenue | 11.9 B | |||
| Gross Profit | 984.31 M | |||
| EBITDA | 443.58 M | |||
| Net Income | 224.64 M | |||
| Cash And Equivalents | 103.76 M | |||
| Cash Per Share | 1.36 X | |||
| Total Debt | 1.16 B | |||
| Debt To Equity | 43.80 % | |||
| Current Ratio | 1.18 X | |||
| Book Value Per Share | 22.62 X | |||
| Cash Flow From Operations | 143.63 M | |||
| Earnings Per Share | 1.64 X | |||
| Price To Earnings To Growth | 4.52 X | |||
| Number Of Employees | 2.68 K | |||
| Beta | 0.36 | |||
| Market Capitalization | 2.98 B | |||
| Total Asset | 6.95 B | |||
| Z Score | 2.2 | |||
| Net Asset | 6.95 B | |||
| Last Dividend Paid | 0.87 |
About EBOS Group Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze EBOS Group Limited's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of EBOS Group using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of EBOS Group Limited based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.EBOS Group Limited engages in the marketing, wholesale, and distribution of healthcare, medical, pharmaceutical, and animal care products in Australia and New Zealand. EBOS Group Limited was founded in 1922 and is headquartered in Docklands, Australia. Ebos Group is traded on BATS Exchange in USA.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for EBOS Pink Sheet Analysis
When running EBOS Group's price analysis, check to measure EBOS Group's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy EBOS Group is operating at the current time. Most of EBOS Group's value examination focuses on studying past and present price action to predict the probability of EBOS Group's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move EBOS Group's price. Additionally, you may evaluate how the addition of EBOS Group to your portfolios can decrease your overall portfolio volatility.